Patents/Assignees

ANAVEX LIFE SCIENCES Corp.

15 patents in portfolio

US12594256utility2026
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-seizure Therapy
0 cites
US12558340utility2026
ANAVEX2-73 for the Treatment of Genetic Neurodevelopmental Disorders
0 cites
US12533352utility2026
Analgesic Therapeutic and Method, 1-(3-4(((1r,3s,5s)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and Salts Thereof
0 cites
US12383526utility2025
Optimized Sigma-1 Agonist Method of Responder Selection and Treatment
0 cites
US12285403utility2025
A2-73 as a Therapeutic for Insomnia, Anxiety and Agitation
0 cites
US12280034utility2025
Sigma-1 Receptor Agonist Systolic Blood Pressure Therapy
0 cites
US12208079utility2025
Enantiomers of A2-73, Analogues, and Sigma Agonist Activity
0 cites
US12180174utility2024
A2-73 Crystalline Polymorph Compositions of Matter and Methods of Use Thereof
0 cites
US12138240utility2024
Treatment of Cardiac Dysfunction
0 cites
US11896590utility2024
Analgesic Therapeutic and Method, 1-(3-4(((1r,3s,5s)-adamantan-1-yl)(phenyl)methyl)propyl)-4-methylpiperazine and Salts Thereof
0 cites
US11839600utility2023
Neurodevelopmental Disorder Therapy
0 cites
US11813242utility2023
A2-73 as a Therapeutic for Insomnia, Anxiety, and Agitation
0 cites
US11690821utility2023
A19-144, A2-73 and Certain Anticholinesterase Inhibitor Compositions and Method for Anti-seizure Therapy
0 cites
US11661405utility2023
Crystal Forms of Tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine Hydrochloride, Processes of Making Such Forms, and Their Pharmaceutical Compositions
0 cites
US11622955utility2023
Sigma-1 Receptor Agonist Systolic Blood Pressure Therapy
0 cites